Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation ; volume:14 ; number:1 ; day:9 ; month:9 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (9.9.2024), 1-12, 12.2024
- Creator
-
Mohseni, Rashin
Mahdavi Sharif, Pouya
Behfar, Maryam
Shojaei, Sahar
Shoae-Hassani, Alireza
Jafari, Leila
Khosravi, Abbas
Nikfetrat, Zeynab
Hamidieh, Amir Ali
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-70958-7
- URN
-
urn:nbn:de:101:1-2411232119244.913901489413
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mohseni, Rashin
- Mahdavi Sharif, Pouya
- Behfar, Maryam
- Shojaei, Sahar
- Shoae-Hassani, Alireza
- Jafari, Leila
- Khosravi, Abbas
- Nikfetrat, Zeynab
- Hamidieh, Amir Ali
- SpringerLink (Online service)
Other Objects (12)
The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
Management of relapsed-refractory diffuse large B cell lymphoma
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
Relapsed/refractory diffuse large b-cell lymphoma: is there still a role for autologous stem cell transplantation in the CAR T-cell era?
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Analysis of Relapsed/Refractory Hodgkin Lymphoma Treated with Autologous Transplantation: A Single-Center Experience
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma
The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
Management of relapsed-refractory diffuse large B cell lymphoma
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
Relapsed/refractory diffuse large b-cell lymphoma: is there still a role for autologous stem cell transplantation in the CAR T-cell era?
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Analysis of Relapsed/Refractory Hodgkin Lymphoma Treated with Autologous Transplantation: A Single-Center Experience
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective
Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma
The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
Management of relapsed-refractory diffuse large B cell lymphoma
Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma
Relapsed/refractory diffuse large b-cell lymphoma: is there still a role for autologous stem cell transplantation in the CAR T-cell era?
Consolidative allogeneic hematopoietic stem cell transplantation after chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: who? When? Why?
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
Analysis of Relapsed/Refractory Hodgkin Lymphoma Treated with Autologous Transplantation: A Single-Center Experience
Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective